Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The stem cell factor receptor, also known as c-Kit or CD117, is a type III receptor tyrosine kinase. It is activated by its ligand, stem cell factor (SCF), leading to dimerization and autophosphorylation. Activated c-Kit initiates downstream signaling pathways that regulate cell survival, proliferation, migration, and differentiation. It is expressed on hematopoietic stem cells, mast cells, melanocytes, germ cells, and other cell types. Deregulated c-Kit activity is implicated in various diseases, including gastrointestinal stromal tumors (GISTs), piebaldism, and allergic responses.
Small-molecule inhibitors that target the tyrosine kinase activity of c-Kit, blocking its signaling pathways.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Stem Cell Factor Receptor KIT (c-Kit).